Industry
Market Analysts see Design Therapeutics Inc [DSGN] falling to $6. Time to buy?
Design Therapeutics Inc [NASDAQ: DSGN] traded at a high on Thursday, posting a 3.07 gain after which it closed the day’ session at $4.03. The company report on March 19, 2024 at 4:01 PM that Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth
